Disposable NFC Biomarker Patches
In 2004, Gentag broadly patented the use of NFC sensors combined with disposable skin patches and biomarkers. Biomarkers are present in any fluid in the body, including sweat, and can identify a host of health and medical conditions.
This patented technology is covered under issued patents in North America, Asia and Europe.
The detection of toxins, specific proteins, and DNA in very small fluid samples is increasingly possible using advanced nanomaterials. The Gentag biomarkers platform is covered by over 40 issued patents (held in our patent holding company Altivera, LLC). Gentag is working with some of the leaders in microelectronics and biosensors to develop cutting-edge printable molecular-level sensors.
Disposable NFC Lab-on-a-Chip
NFC can be combined with lab-on-a-chip microfluidics technology to create a powerful new platform for advanced on-the-spot diagnostics with cell phones. The technology can be used for protein detection, DNA or RNA analyses, or drug delivery.
Disposable NFC Rapid Tests
Rapid tests or lateral flow immunoassays are disposable antibody-based diagnostic tests to detect specific proteins from biomarkers, allergens or infectious diseases such as Covid-19. Gentag has patented the next generation technology to make these convenient low cost and highly accurate tests directly compatible with mobile devices for on-the-spot testing and interpretation anywhere. Gentag’s proprietary patented technology will enable the use of printable, battery-less wireless rapid tests that can be read directly with smartphones. An application example is a rapid test for Covid-19 exposure.
Sensor Arrays for Phones
Gentag owns a number of groundbreaking patents covering the uses of person-specific chemicals sensors in cell phones for threat and allergen detection. Using the patented Gentag “e-nose” technology, a mobile device can be trained to recognize the environmental factors that trigger asthma or an allergic reaction in a given individual, allowing the creation of truly personalized genomic devices.